Johnson David Michael made two open market purchases of Aura Biosciences ($AURA) shares in the last year, totaling $98,000, with the most recent on May 16, 2025. This ranks 2,398th among nearly 5,000 insiders, below the average of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | A | Stock Option (Right to Buy) | 17000 | $0.00 | 17,000.0000 | 49,650,480 | 9999.99% | 0.03% |
| June 17, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Johnson David Michael | Director | A | Common Stock | 57603 | $0.00 | 250,421.0000 | 71,811,508 | 29.87% | 0.08% |
| June 17, 2025 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | A | Common Stock | 13000 | $0.00 | 468,839.0000 | 49,650,480 | 2.85% | 0.03% |
| May 16, 2025 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | P | Common Stock | 20000 | $4.90 | 455,839.0000 | 49,650,480 | 4.59% | 0.04% |
| May 16, 2025 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | P | Common Stock Warrants (right to buy) | 5000 | $0.00 | 5,000.0000 | 49,650,480 | 9999.99% | 0.01% |
| June 20, 2024 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | A | Common Stock | 10500 | $0.00 | 435,839.0000 | 39,620,036 | 2.47% | 0.03% |
| June 20, 2024 | Aura Biosciences, Inc. | $AURA | Johnson David Michael | Not found | A | Stock Option (Right to Buy) | 14500 | $0.00 | 14,500.0000 | 39,620,036 | 9999.99% | 0.04% |
| June 21, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Johnson David Michael | Director | A | Common Stock | 48429 | $0.00 | 192,818.0000 | 0 | 33.54% | 0.00% |